Trends in Hospitalization, Management, and Clinical Outcomes Among Veterans With Critical Limb Ischemia.


Journal

Circulation. Cardiovascular interventions
ISSN: 1941-7632
Titre abrégé: Circ Cardiovasc Interv
Pays: United States
ID NLM: 101499602

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 19 2 2020
pubmed: 19 2 2020
medline: 1 9 2020
Statut: ppublish

Résumé

Contemporary patterns in management and outcomes of critical limb ischemia among United States veterans are unknown. We used Veterans Health Administration data to identify patients admitted for critical limb ischemia between 2005 and 2014. We examined temporal trends in incidence, management, and outcomes. A total of 20 938 veterans with critical limb ischemia were hospitalized between 2005 and 2014. Mean age was 67.8 years. Incidence decreased from 0.3 to 0.24 per 1000 persons from 2005 to 2013, Over the past decade, use of revascularization increased among veterans with critical limb ischemia, which was accompanied by a reduction in mortality and major amputation. However, opportunities to further improve care in this high-risk population still remain.

Sections du résumé

BACKGROUND
Contemporary patterns in management and outcomes of critical limb ischemia among United States veterans are unknown.
METHODS
We used Veterans Health Administration data to identify patients admitted for critical limb ischemia between 2005 and 2014. We examined temporal trends in incidence, management, and outcomes.
RESULTS
A total of 20 938 veterans with critical limb ischemia were hospitalized between 2005 and 2014. Mean age was 67.8 years. Incidence decreased from 0.3 to 0.24 per 1000 persons from 2005 to 2013,
CONCLUSIONS
Over the past decade, use of revascularization increased among veterans with critical limb ischemia, which was accompanied by a reduction in mortality and major amputation. However, opportunities to further improve care in this high-risk population still remain.

Identifiants

pubmed: 32069107
doi: 10.1161/CIRCINTERVENTIONS.119.008597
pmc: PMC8641646
mid: NIHMS1758467
doi:

Substances chimiques

Hydroxymethylglutaryl-CoA Reductase Inhibitors 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e008597

Subventions

Organisme : HSRD VA
ID : I21 HX002365
Pays : United States

Références

Circulation. 2017 Mar 21;135(12):e726-e779
pubmed: 27840333
J Am Coll Cardiol. 2016 Apr 26;67(16):1901-13
pubmed: 27012780
Circulation. 2015 Nov 10;132(19):1805-15
pubmed: 26350058
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):94-102
pubmed: 22147886
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
Tech Vasc Interv Radiol. 2014 Sep;17(3):221-4
pubmed: 25241324
J Vasc Surg. 2010 Jan;51(1):230-41
pubmed: 20117502
J Vasc Surg. 2014 Sep;60(3):686-95.e2
pubmed: 24820900
J Vasc Surg. 2017 Aug;66(2):476-487.e1
pubmed: 28408154
J Vasc Surg. 2018 Aug;68(2):527-535.e5
pubmed: 29588132
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
J Vasc Surg. 2013 Jun;57(6):1471-79, 1480.e1-3; discussion 1479-80
pubmed: 23375611
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648

Auteurs

Amgad Mentias (A)

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City (A.M., A.Q., M.V.-S., S.G.).

Abdul Qazi (A)

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City (A.M., A.Q., M.V.-S., S.G.).

Kimberly McCoy (K)

Department of Veterans Affairs, Comprehensive Access and Delivery Research and Evaluation, Iowa City VA Medical Center (K.M., M.V.-S., S.G.).

Robert Wallace (R)

College of Public Health, University of Iowa, Iowa City (R.W.).

Mary Vaughan-Sarrazin (M)

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City (A.M., A.Q., M.V.-S., S.G.).
Department of Veterans Affairs, Comprehensive Access and Delivery Research and Evaluation, Iowa City VA Medical Center (K.M., M.V.-S., S.G.).

Saket Girotra (S)

Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City (A.M., A.Q., M.V.-S., S.G.).
Department of Veterans Affairs, Comprehensive Access and Delivery Research and Evaluation, Iowa City VA Medical Center (K.M., M.V.-S., S.G.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH